KIAA0368 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.222800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.243600E-01
Normal-vs-Stage2
5.299200E-01
Normal-vs-Stage3
2.958300E-02
Normal-vs-Stage4
9.631600E-01
Stage1-vs-Stage2
7.585800E-01
Stage1-vs-Stage3
7.766200E-02
Stage1-vs-Stage4
6.709400E-01
Stage2-vs-Stage3
3.915600E-02
Stage2-vs-Stage4
4.408400E-01
Stage3-vs-Stage4
2.457500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.066800E-01
Normal-vs-AfricanAmerican
9.485600E-01
Normal-vs-Asian
5.817400E-01
Caucasian-vs-AfricanAmerican
5.416000E-01
Caucasian-vs-Asian
9.225400E-01
AfricanAmerican-vs-Asian
5.785000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.230800E-01
Normal-vs-Female
6.278400E-01
Male-vs-Female
9.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.001790E-01
Normal-vs-Age(41-60Yrs)
9.742800E-01
Normal-vs-Age(61-80Yrs)
4.973800E-01
Normal-vs-Age(81-100Yrs)
2.944800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.766980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.780600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.327000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.115820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.368400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.258200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.813200E-01
Normal-vs-Daily Drinker
2.771600E-01
Normal-vs-Weekly Drinker
3.193400E-01
Normal-vs-Occasional Drinker
8.891000E-01
Normal-vs-Social Drinker
8.265800E-01
Non Drinker-vs-Daily Drinker
7.998800E-01
Non Drinker-vs-Weekly Drinker
5.292400E-01
Non Drinker-vs-Occasional Drinker
9.294000E-02
Non Drinker-vs-Social Drinker
2.069900E-02
Daily Drinker-vs-Weekly Drinker
6.657800E-01
Daily Drinker-vs-Occasional Drinker
1.443840E-01
Daily Drinker-vs-Social Drinker
3.314400E-02
Weekly Drinker-vs-Occasional Drinker
3.219200E-01
Weekly Drinker-vs-Social Drinker
9.845800E-02
Occasional Drinker-vs-Social Drinker
5.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.835030E-01
Normal-vs-Grade 2
7.322200E-02
Normal-vs-Grade 3
5.218400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.446200E-01
Grade 1-vs-Grade 3
7.789800E-01
Grade 1-vs-Grade 4
1.835030E-01
Grade 2-vs-Grade 3
5.871400E-01
Grade 2-vs-Grade 4
7.322200E-02
Grade 3-vs-Grade 4
5.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.504000E-01
Normal-vs-NonDiabetic
6.448000E-01
Diabetic-vs-NonDiabetic
8.249800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.034000E-01
Normal-vs-NoPancreatitis
5.497800E-01
Pancreatitis-vs-NoPancreatitis
8.065200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.029200E-01
Normal-vs-N1
5.502800E-01
N0-vs-N1
4.329400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.662200E-01
Normal-vs-TP53-NonMutant
9.912200E-01
TP53-Mutant-vs-TP53-NonMutant
4.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
